Skip to main content

UBS Group AG

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in NRXP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,730,539
+$1,676,807 QoQ
Shares Held
423,115
+1577.2% QoQ
Ownership
0.977%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 47 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. NRXP ranks #221 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NRXP

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,730,539 423,115
2026-03-31 $53,732 25,227
2025-12-31 $9,587 3,538
2025-09-30 $504,397 152,848
2025-06-30 $396,441 121,608
2025-03-31 $215 105
2024-12-31 $330 150
2024-09-30 $64 38
2024-06-30 $2,651 1,087
2024-03-31 $7,821 16,571
2023-12-31 $21,545 46,837
2023-09-30 $314 1,210
2023-06-30 $1,334 2,758
2023-03-31 $12,264 18,611
2022-12-31 $432 390
2022-06-30 $10,078 16,798
2022-03-31 $11,091 4,527
2021-12-31 $56,125 11,742
2021-06-30 $97,433 8,385
2020-12-31 BRPA 227
2020-09-30 BRPA 460
2020-06-30 BRPA 829
2020-03-31 BRPA 2,029